MedTrace Logo

Life at 100.4: An Immersive Social Virtual Reality (VR) Education Tool for Adolescent and Young Adult Cancer Patients and Caregivers

NCT07224204 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2026-02-25

No results posted yet for this study

Summary

The purpose of this study is to design and Beta test the Life at 100.4, an immersive social virtual reality education tool, with an anticipated 5 patient-caregiver-provider triads.Patients at Yale Pediatric Hematology and Oncology with a new oncologic diagnosis and their caregivers will be eligible for enrollment. Investigators will determine the feasibility and acceptability of implementing Life at 100.4 using validated measures.

Conditions

  • Cancer
  • Adolescent Cancer
  • Young Adult Cancer

Interventions

BEHAVIORAL

Life at 100.4

An Immersive Social Virtual Reality Education Tool, participation up to 2 hours

Sponsors & Collaborators

  • The Glimpse Group Inc

    collaborator UNKNOWN

  • National Institute of Nursing Research (NINR)

    collaborator NIH

  • Yale University

    lead OTHER

Principal Investigators

  • Asher Marks, MD · Yale University

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
13 Years
Max Age
39 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-02-11
Primary Completion
2027-04-30
Completion
2027-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07224204 on ClinicalTrials.gov